Jong-Hoon Kim
Psychiatry Jong-Hoon Kim Favorite Doctor
  • SpecialtySchizophrenia‚ organic mental disorder‚ mood disorder‚ panic disorder, molecular brain imaging
  • Site
의료진 진료일정
Week M T W T F S
AM       Present    
PM   Present   Present Present  
Clinical Interests

Schizophrenia‚ organic mental disorder‚ mood disorder‚ panic disorder, molecular brain imaging

1987~1989 서울대학교 의예과
1993 서울대학교 의과대학 의학과 졸업
2002 서울대학교 대학원 의학석사학위 취득 (정신과학 전공)
2005 서울대학교 대학원 의학박사학위 취득 (정신과학 전공)
1993~1994 서울대학교병원 인턴
1994~1998 서울대학교병원 정신과 레지던트, 정신과 전문의 취득 (1998)
1998~2001 군복무
2001~2003 서울대학교병원 정신과 전임의/임상강사
2003~2007 가천의과대학교 정신과 조교수
2006~2007 미국 New York 컬럼비아 의대 정신과 방문 조교수
2007~2012 가천대학교 의과대학 정신건강의학과 부교수
2012~ 가천대학교 의과대학 정신건강의학과 교수
2014~ 가천대 뇌과학연구원 정신의학연구센터장
2012~2022 가천대 길병원 IRB 1패널 위원장
2022~현재 가천대 길병원 임상시험센터장
Awards & Honors
2006 Paul Janssen Schizophrenia Research Award (대한신경정신의학회)
2012 가천학술상 (가천대학교)
2012 가천의학연구상 (가천의과학대학교)
2005 우수 연구자상 (가천의과학대학교)
2006 Marquis Who's Who in Science and Engineering
2011 New Research Award (Asian College of Neuropsychopharmacology)
2001 우수 논문 (대한신경정신의학회 추계학술대회)
1997 우수 논문 (대한신경정신의학회 추계학술대회)
International Editorial Board: Synapse (2021.5-현재, SCI IF: 2.545)
International Editorial Board: Australian and New Zealand Journal of Psychiatry (2011.5-2021.12, SCI IF: 5.744)
대한신경정신의학회 정회원
대한조현병학회 교육이사
대한조현병학회 정보이사
대한조현병학회 이사
대한조현병학회지 편집위원: 2004.4-현재
대한정신약물학회 정회원
Member of Scientific Committee: Asian Congress on Schizophrenia Research
대한노인정신의학회 노인정신건강 인증의
대한노인정신의학회 정회원
주요 정신장애(정신분열병, 우울증) 한국형 치료 알고리듬 개발위원회 실무위원/검토위원
American Neuropsychiatric Association 회원
Movement Disorder Society 회원
2006~2007 미국 뉴욕 Columbia 의대 정신과, Division of Translational Imaging / Columbia University Medical Center, New York Presbyterian Hospital
1993 의사면허 취득
1998 정신과 전문의 취득
2008 노인정신건강 인증의
Jong-Hoon Kim
Books/Book chapters:
2013 - 조현병, 마음의 줄을 고르다 (2013년, 군자출판사)
2009 - Psychiatric Disorders. In "Functional Cerebral SPECT and PET Imaging, 4th edition" (Lippincott Williams & Wilkins, September, 2009)
2008 - Molecular Brain Imaging Research in Mental Illness. In "Neurobiology of Mental Illness, 3rd Edition" (Oxford University Press, December, 2008)
2006 - 한국형 정신분열병 약물치료 지침서 2006 (2006년, CFcom)
2004 - 비정형 항정신병제의 임상 (2004년 서울대학교 출판부)
2004 - 보완대체의학 (2004년 이한출판사)
2000 - 정신의학 (2000년 일조각)
Selected Publications:
2022 - Son et al. Future Prospects of Positron Emission Tomography-Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders. Pharmaceuticals. 2022;15(5):583. doi: 10.3390/ph15050583
2022 - Joo et al. In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [11C]PK11195 PET Study. Biomedicines. 2022;10(1):34. doi: 10.3390/biomedicines10010034
2021 - Choi et al. Deep graph neural network-based prediction of acute suicidal ideation in young adults. Scientific Reports. 2021;11(1):15828.
2021 - Kim et al. Sex Difference in Peripheral Inflammatory Biomarkers in Drug-Naïve Patients with Major Depression in Young Adulthood. Biomedicines. 2021;9(7):708.
2021 - Joo et al. Functional analysis of brain imaging suggests changes in the availability of mGluR5 and altered connectivity in the cerebral cortex of long-term abstaining males with alcohol dependence: a preliminary study. Life. 2021;11(6):506.
2021 - Kim et al. Association between lack of insight and prefrontal serotonin transporter availability in antipsychotic-free patients with schizophrenia: a high-resolution PET study with [11C]DASB. Neuropsychiatr Dis Treat. 2021;17:3195-3203.
2021 - Vo et al. Ag-deposited porous silicon as a SERS-active substrate for the sensitive detection of catecholamine neurotransmitters. Electronic Materials Letters. 2021;17:292–298.
2020 - Kim et al. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [11C]ABP688 PET and diffusion tensor imaging study. Brain Struct Funct. 2020;225(6):1805-1816.
2020 - Joo et al. In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [18F]FDG microPET and MRS. EJNMMI Res. 2020;10(1):116.
2020 - Kim et al. A Review of Molecular Imaging of Glutamate Receptors. Molecules. 2020 Oct 16;25(20):E4749.
2019 - Kim et al. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naive young adults with major depression. European Neuropsychopharmacology. 2019;29(2):278-290
2019 - Kim et al. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [(18)F]fallypride PET and fMRI study. Synapse. 2019 Nov;73(11):e22121. doi: 10.1002/syn.22121.
2018 - Phung et al. Reliable and quantitative SERS detection of dopamine levels in human blood plasma using a plasmonic Au/Ag nanocluster substrate. Nanoscale. 2018 Dec;10(47):22493-22503
2018 - Kim et al. Penalized PET reconstruction using deep learning prior and local linear fitting. IEEE Transactions on Medical Imaging. 2018 ;37(6):1478-1487
2018 - Kim et al. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18F]fallypride PET and functional MRI study. Synapse. 2018 Dec;72(12):e22064. doi: 10.1002/syn.22064.
2018 - Kim et al. Neural signature for auditory hallucinations in schizophrenia: a high-resolution positron emission tomography study with fludeoxyglucose (18F). Clin Psychopharmacol Neurosci. 2018;16(3):324-332
2018 - Phung et al. Gold nanostructures electrodeposited on graphene oxide-modified indium tin oxide glass as a surface-enhanced Raman scattering-active substrate for ultrasensitive detection of dopamine neurotransmitter. Japanese Journal of Applied Physics 2018;57:08PF02
2018 - Joo YH et al. The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: A high-resolution PET study with [18F]fallypride. European Archives of Psychiatry and Clinical Neuroscience 2018 Sep;268(6):529-540.
2017 - Kim JH et al. Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study. Psychopharmacology (Berl). 2017 Jun;234(12):1923-1932.
2017 - Kim JH et al. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG. Schizophrenia Research 2017 Apr;182:55-65.
2017 - Lee et al. Prevalence of metabolic syndrome in patients with schizophrenia in Korea: a multicenter nationwide cross-sectional study. Psychiatry Investig. 2017; 14(1):44-50
2016 - Shin Y et al. Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia. Neuropsychiatr Dis Treat. 2016;12:1411-1417.
2016 - Kinoshita et al. Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study. Psychopharmacology (Berl). 2016;233(14):2663-2674
2016 - Kim et al. Diminished autonomic neurocardiac function in patients with generalized anxiety disorder. Neuropsychiatr Dis Treat. 2016;12:3111-3118.
2016 - Kang NI et al. Efficacy and tolerability of paliperidone extended-release in the treatment of first-episode psychosis: an eight-week, open-label, multicenter trial. Clin Psychopharmacol Neurosci 2016;14(3):261-269.
2015 - Kim JH et al. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: an ultra-high resolution PET-MRI study. Brain Research 2015;1629:63-71
2015 - Kim JH et al. Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2041-8.
2015 - Kim JH et al. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET. Psychiatry Research 2015;231:50-57.
2014 - Son YD et al. Individually differentiated serotonergic raphe nuclei measured with brain PET/MR imaging. Radiology 2014;272(2):541-548.
2014 - Kim JH et al. Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [11C]raclopride. Acta Neuropsychiatrica 2014;26(1):35-42.
2014 - Kim JH et al. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine. Comprehensive Psychiatry 2014;55(3):708-713
2014 - Park JI et al. The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis. Int Clin Psychopharmacol. 2014;29(2):77-85.
2013 - Kim JH et al. Effects of clozapine on heart rate dynamics and their relationship with therapeutic response in treatment-resistant schizophrenia.
Journal of Clinical Psychopharmacology 2013;33(1):69-73
2013 - Kim JH et al. Anomalous subjective experiences in schizophrenia, bipolar disorder, and unipolar depression. Comprehensive Psychiatry 2013;54(5):447-453
2013 - Kim JH et al. Relationship of oestrogen receptor status to depressive symptoms and quality of life in breast cancer patients. Acta Neuropsychiatrica 2013;25(5):283-288.
2013 - Kim JH et al. Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia. Neuropsychiatr Dis Treat. 2013;9:989-94.
2012 - Kim JH et al. Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Research 2012;197(3):285-289
2012 - Park HY et al. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: A 12-week, open-label prospective trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012;36:318-323.
2011 - Kim JH, et al. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C] raclopride. Journal of Clinical Psychopharmacology 2011;31:507-511
2011 - Kim JH, et al. Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study. European Neuropsychopharmacology 2011;21(12):885-891
2011 - Kim JH, et al. Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: A high resolution PET study. Biol Psychol 2011;87(1):164-167.
2011 - Bullich S, et al. Biodistribution and Radiation Dosimetry of the Glycine Transporter-1 Ligand (11)C-GSK931145 Determined from Primate and Human Whole-Body PET. Mol Imaging Biol. 2011;13(4):776-84.
2011 - Lee JS, et al. Dose pattern and effectiveness of paliperidone extended-release tablets in patients with schizophrenia. Clinical Neuropharmacology 2011;34:186-190.
2011 - Kim JH. Subjective experiences in schizophrenia. Australian and New Zealand Journal of Psychiatry 2011;45(3):262.
2011 - Kim JH, et al. Relationship between heart rate variability and the severity of psychotic symptoms in schizophrenia. Acta Neuropsychiatrica 2011;23(4):161-166
2011 - Kim JH, et al. Insight change and its relationship to subjective well-being during acute atypical antipsychotic treatment. J Clin Pharm Ther 2011;36(6):687-694.
2011 - Kim JH, et al. Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics. J Clin Pharm Ther 2011;36(2):172-178
2010 - Lee YW, et al. Subjective well-being in patients with schizophrenia treated with atypical antipsychotics. Clinical Psychopharmacology and Neuroscience 2010;8:130-136
2010 - Kim JH, et al. Relationship between subjective experiences and psychopathological dimensions in schizophrenia. Aust N Z J Psychiatry. 2010;44(10):952-957.
2010 - Kim JH, Byun HJ. The relationship between akathisia and subjective tolerability in patients with schizophrenia. Int J Neurosci 2010;120(7):507-511
2010 - Kim JH, et al. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia. Compr Psychiatry 2010;51:165-170
2010 - Bae et al. Gender difference in the association between adult attention deficit hyperactivity disorder symptoms and morningness–eveningness. Psychiatry Clin Neurosci. 2010;64:649-51.
2009 - Kim JH, et al. The pNNx heart rate variability statistics: an application to clozapine-treated subjects. Psychiatry Investigation 2009;6:294-298
2009 - Kim JH, et al. Association of adverse drug effects with subjective well-being in patients with schizophrenia receiving stable doses of risperidone. Clinical Neuropharmacology 2009;32(5):250-253
2009 - Kim JH, Byun HJ. Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism. Human Psychopharmacology-Clinical and Experimental 2009;24:129-133.
2009 - Chang JS, et al. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia. Australian and New Zealand Journal of Psychiatry 2009;43:244-251.
2008 - Kegeles LS, et al. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 2008:33(13):3111-25
2008 - Jeong SH, et al. A 2-year prospective follow-up study of lower urinary tract symptoms in patients treated with clozapine. J Clin Psychopharmacol. 2008;28:618-24.
2008 - Jung HY, et al. Measuring psychosis proneness in a nonclinical Korean population: is the Peters et al Delusions Inventory useful for assessing high-risk individuals? Compr Psychiatry. 2008;49(2):202-210.
2008 - Kim JH, Kim SY, Byun HJ. Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia. Parkinsonism & Related Disorders 2008;14(3):239-42.
2007 - Martinez D, Kim JH, Krystal J, Abi-Dargham A. Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clinics of North America 2007:17(4):539-55.
2007 - Kim JH, Byun HJ. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol. Journal of Clinical Pharmacy and Therapeutics 2007:32:461-467
2006 - Kim JH, Park CY, Lee SJ. Effects of Sun Ginseng on subjective quality of life in cancer patients: A double-blind, placebo-controlled pilot trial. Journal of Clinical Pharmacy and Therapeutics 2006:31(4):331-334
2006 - Kim JH, Yi SH, Park KT, Ahn YM, Lee KY, Yang SA, Kim YS. Diminished Neurocardiac Dynamics Associated With Antipsychotic-induced Extrapyramidal Syndrome. European Neuropsychopharmacology 2006:16(6):459-463
2006 - Kim JH, Kim SY, Ahn YM, Kim YS. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006:30(2):301-305
2005 - Kim JH, Jin YH, Kang UG, Ahn YM, Ha KS, Kim YS. Neuroleptic-induced acute and chronic akathisia: a clinical comparison. Movement Disorders 2005:20(12):1667-1670
2005 - Ahn YM, et al. Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment. Int Clin Psychopharmacol. 2005;20(3):157-161.
2005 - Jung HY, et al. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia. Human Psychopharmacology-Clinical and Experimental. 2005;20(1):41-45.
2004 - Kim JH, Cho SY, Byun HJ, Kang UG, Ahn YM, Kim YS. Multidimensional sensory phenomena in antipsychotic-induced akathisia. Journal of Clinical Psychopharmacology. 2004:24(6):618-623.
2004 - Kim JH, et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004:28(2):371-378
2003 - Kim JH, Byun HJ. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects. Clinical Neuropharmacology 2003:26(6):312-316
2002 - Kim JH, et al. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Comprehensive Psychiatry 2002:43(6):456-462
2002 - Kim JH, et al. Metric characteristics of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS): a practical rating scale for drug-induced movement disorders. Movement Disorders 2002:17(6):1354-1359
International Editorial Board
Australian and New Zealand Journal of Psychiatry (2011-present, SCI IF: 5.084)
Journal Reviewer (Ad hoc)
Psychopharmacology (Berl): 2015, 2016
PLOS One: 2013
Schizophrenia Research: 2012
Psychiatry Research: 2006, 2012, 2013
BMC Neurology: 2004-2005, 2007
Psychiatry Investigation: 2005-2013
Alzheimer Disease and Associated Disorders: 2010
Acta Neuropsychiatrica: 2011
Clinical Psychopharmacology and Neuroscience: 2013-
Clinical Practice and Epidemiology in Mental Health: 2010
Journal of Korean Neuropsychiatric Association (Korean): 2006-2010
Korean Journal of Schizophrenia Research (Korean): 2008-present